plain.png

PIONEERING VIRTUAL BIOPSIES

Live cellular imaging without incisions

only_logo.png

Where live imaging and deep data meet.

Enspectra Health is pioneering a new field of virtual biopsies to transform the way physicians evaluate a broad spectrum of skin conditions. 

 

Our novel technology combines reflectance confocal and multiphoton laser scanning microscopy to generate real-time, multispectral images spanning wavelengths not seen with the naked eye. The unique integration of these technologies produces images with increased depth, greater cellular detail, and more distinctive color contrast.

 

Our platform technology delivers pulsed near-infrared light through the skin’s surface, providing high-resolution images at the cellular level, without the need for an incision. The technology allows for an instantaneous evaluation of rich, digital pathology images of various skin tissues, potentially enabling earlier and less costly interventions.

 
Histology_0202.jpg
AI Face of Woman_Final.jpg

Enspectra Health is developing a device targeted at dermatologists to aid in the evaluation of a variety of skin conditions including nonmelanoma skin cancers (NMSCs).

 

Leveraging our novel platform technology, high-resolution, cellular images of the skin are produced noninvasively.  

 

By arming clinicians with rich skin tissue images, we hope to aid in more informed decision making, with the ultimate goal of minimizing unnecessary biopsies, leading to earlier disease diagnosis and interventions. 

"Our mission is to develop and deploy technologies focused on earlier disease detection, leveraging revolutionary imaging and machine learning, in order to transform patient care."

 - Gabriel Sanchez, CEO Enspectra Health

Face%2520Montage%2520Revised_0201_edited

Cut Out Unnecessary Biopsies

 

 THE TEAM

Gabriel Sanchez Smile.jpg

GABRIEL SANCHEZ

CoFounder & CEO

Leveraging his extensive experience innovating in the fields of optics and electromechanical devices, Gabriel serves as the visionary for Enspectra Health. Working with a team of experts, Gabriel is leading the rapid advancement and development of Enspectra's multiphoton imaging device to evaluate a broad spectrum of skin conditions. 

Bill Beasley.jpg

BILL BEASLEY

President & COO

Bill has over 20 years of experience in medical device executive management, operations, manufacturing, supply chain, and infrastructure. He has supported product launches and scale up activities at several device startups, leading to acquisitions by companies such as Hologic, Medtronic and Stryker Corporation. 

Kate Montgomery.jpg

KATE MONTGOMERY

Director of Scientific Affairs

Kate is an engineer and scientist who has spent the last 10 years developing cutting edge medical technologies in neuroscience and dermatology. Leveraging her experience, Kate leads scientific strategy for Enspectra Health. Kate holds a PhD in Bioengineering from Stanford University and a BS in Bioengineering from Rice University.

Mark_Shugart.jpg

MARK SHUGHART

Director of Systems Engineering

Mark has over a decade of experience advising and designing novel technologies for several device companies. Mark brings a wealth of knowledge in the areas of hardware, electrical and firmware engineering, rapid prototyping, and supply chain optimization. 

MARK SCHNITZER

CoFounder

Mark is a professor of biology and applied physics at Stanford University who has pioneered microendoscopy for in vivo imaging.  An expert in the custom design of optical instrumentation and multiphoton imaging techniques, his research at Stanford has spawned multiple scientific breakthroughs. 

SCOTT DELP

CoFounder & Director

Scott is the Director of the Stanford Neuromuscular Biomechanics Laboratory. He has cofounded several companies, including Musculographics (now Motion Analysis Corp), Surgical Graphics (acquired by Medtronic), Cala Health, Enspectra Health, and Circuit Therapeutics. 

 
Texture #1.jpg

NEWS

 

Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough

A $2 Million Grant From the National Cancer Institute A Highlight of a Noteworthy Year for Enspectra Health

Meet Gabriel Sanchez, CEO of Enspectra Health

Enspectra Health Receives $4.0 Million NIH Grant to Advance a New Field of Virtual Biopsies

SUPPORTED BY

10.jpg
1.jpg
7.jpg
9.jpg
11.jpg
12.jpg
5.jpg
6.jpg
13.png
3.jpg
 

CONTACT US

2495 Hospital Drive, Suite 300
Mountain View, CA  94040

(650) 480-6022

Team Photo.jpg

Thanks for submitting!

Histology_0202.jpg

Follow our progress.